Breaking News Headlines Today | Ground News

See every side of every news story

Healio image

News from Healio

Stay current with all the latest and breaking news from Healio. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 40 of Healio’s headlines and news stories over the past 3 months.

Healio’s media bias is Center. Ground News assigned this score by aggregating media bias ratings of a Center rating from Ad Fontes Media .

Healio’s factuality rating is Very High. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Healio

Where is Healio located?Healio's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byAd Fontes Media

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Healio News

House passes Trump’s megabill, sending it to the president’s desk

Big Beautiful Bill · United States

House passes Trump’s megabill, sending it to the president’s desk

49% Center coverage: 763 sources

The House on Thursday passed President Donald Trump’s massive tax-and-spending bill, delivering him a major political victory and teeing him up to enshrine much of his sweeping domestic agenda into law. The legislation, which Trump has dubbed the “One Big, Beautiful Bill,” contains trillions of dollars in tax cuts and beefed-up immigration enforcement spending and is offset by significant cuts to Medicaid and other programs. See the Story

Doctors, Public Health Organizations Sue RFK Jr. over Vaccine Policy Changes

Robert F. Kennedy Jr. · United States

Doctors, Public Health Organizations Sue RFK Jr. over Vaccine Policy Changes

41% Center coverage: 17 sources

A coalition of doctors groups and public health organizations sued the U.S. government on Monday over the decision to stop recommending COVID-19 vaccinations for most children and pregnant women. The American Academy of Pediatrics, American Public Health Association and four other groups — along with an unnamed pregnant doctor who works in a hospital — filed the lawsuit in federal court in Boston. U.S. health officials, following infectious dise…See the Story

Deaths From Uterine Cancer Projected to Rise Sharply over Next Two Decades

Cancer · United States

Deaths From Uterine Cancer Projected to Rise Sharply over Next Two Decades

83% Center coverage: 12 sources

Uterine cancer rates in the United States are expected to climb significantly over the next 25 years, with Black women projected to face the highest burden, according to a new study.Researchers found that while most cancer rates in the U.S. have declined, uterine cancer incidence increased by 0.7% annually between 2013 and 2022, and death rates rose by 1.6% each year from 2014 to 2023. Black women are already twice as likely to die from uterine …See the Story

Alcon to Acquire LumiThera

GENEVA— Alcon has announced its intention to acquire LumiThera, Inc., a leader in light-based innovations for ophthalmology, and its PBM device for the treatment of early and intermediate dry AMD. LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living with early to intermediate dry AMD. Dry AMD is a progressive disease typically treated in late stage, with limited treatment o…AMD See the Story

New Bispecific T-Cell Engager Approved for Multiple Myeloma

83% Center coverage: 6 sources

(MedPage Today) -- The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA)-directed bispecific antibody...Cancer · United States See the Story

Q&A: Unnecessary cancer screenings continue years after guidelines change

100% Center coverage: 1 sources

Stopping unnecessary cancer screenings can take over a decade after new guidelines are introduced, according to a review published in BMJ Quality & Safety.“Excessive screening opens the door for a lot of negative consequences,” Jennifer H. LeLaurin, PhD, an assistant professor of health outcomes and biomedical informatics at the University of Florida, said in a press release.Gainesville, Florida · Gainesville Read Article

What the Science Says About Sunscreen

100% Center coverage: 2 sources

As temperatures climb and sleeves grow shorter, a familiar ritual returns: slathering on the sunscreen—or perhaps skipping it. Confusion lingers about how to protect our skin from the sun.Science See the Story

CDC Nominee Susan Monarez Sidesteps Questions About Disagreements with RFK in Senate Hearing

54% Center coverage: 108 sources

A key vaccine-focused committee of the Centers for Disease Control and Prevention met Wednesday despite bipartisan protestations and controversy that surrounds the group's membership.CDC · United States See the Story

Deaths From Heart Attacks Are Way Down. Here's What's Killing Us Instead

92% Center coverage: 40 sources

Heart disease deaths fell by 66% in 50 years, yet arrhythmia and heart failure rates are rising. Learn about the shifting trends in heart health.Obesity See the Story

Mifepristone Shown to Reduce A1C in Patients with Difficult-to-Control Type 2 Diabetes and Hypercortisolism

100% Center coverage: 10 sources

Study Results Signal Paradigm Shift in Diabetes Care for Patients with Difficult-to-Control Type 2 DiabetesDiabetes · United States See the Story

Inside Out: Regenerative Medicine for Recessive Dystrophic Epidermolysis Bullosa

80% Center coverage: 5 sources

Epidermolysis bullosa is classified as a genodermatosis, an inherited genetic skin disorder that results in severe, chronic skin blistering with painful and life-threatening complications. Although there is currently no cure for epidermolysis bullosa, concurrent advances in gene and stem cell therapies are converging toward combinatorial therapies that hold the promise of clinically meaningful and lifelong improvement. Recent studies using hemat…Gene Editing See the Story

Breaking News Topics Related to Healio